A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...

When prostate cancer has spread beyond the prostate to nearby lymph nodes and other areas of the body and treatments can no longer slow or stop its growth, you are not alone. Many patients, despite ...

Stage 2 prostate adenocarcinoma is localized, with a nearly 100% five-year relative survival rate. Diagnosis uses the TNM system, PSA levels, and Gleason score to determine cancer stage and risk.

If you or a loved one has been diagnosed with prostate cancer, you’re not alone—and you don’t have to wait long to take the next step. Whether you’re newly diagnosed, moving from active surveillance ...

A new means of prostate cancer screening could emerge as an alternative to the PSA test, which has long been the first-line option. Using machine learning, a form of artificial intelligence, Swedish ...

Prostate-specific membrane antigen (PSMA)-PET appeared to cut the risk for treatment failure by half in patients receiving salvage radiotherapy (RT) after radical prostatectomy, without increasing ...

If a person has an “aggressive” prostate cancer with a Gleason score of 9, what does that mean? What’s the outlook when it comes to survival rate and prognosis? Every cancer survivor is unique, of ...

AI is becoming crucial in prostate cancer care, improving diagnosis and treatment stratification through enhanced imaging and risk assessment. AI-generated cancer mapping has shown superior accuracy ...